SEIZALAM Drug Patent Profile
✉ Email this page to a colleague
When do Seizalam patents expire, and what generic alternatives are available?
Seizalam is a drug marketed by MMT and is included in one NDA.
The generic ingredient in SEIZALAM is midazolam hydrochloride. There are nine drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the midazolam hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Seizalam
A generic version of SEIZALAM was approved as midazolam hydrochloride by FRESENIUS KABI USA on June 20th, 2000.
Summary for SEIZALAM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 36 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,090 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in SEIZALAM? | SEIZALAM excipients list |
| DailyMed Link: | SEIZALAM at DailyMed |
Recent Clinical Trials for SEIZALAM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Joint Project Management Office for Chemical, Biological, Radiological, and Nuclear Medical | Phase 1 |
| Rafa Laboratories | Phase 1 |
| Ology Bioservices | Phase 1 |
Pharmacology for SEIZALAM
| Drug Class | Benzodiazepine |
Anatomical Therapeutic Chemical (ATC) Classes for SEIZALAM
US Patents and Regulatory Information for SEIZALAM
SEIZALAM is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting SEIZALAM
TREATMENT OF STATUS EPILEPTICUS IN ADULTS
Exclusivity Expiration: ⤷ Try a Trial
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mmt | SEIZALAM | midazolam hydrochloride | SOLUTION;INTRAMUSCULAR | 209566-001 | Sep 14, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
